Cancer NetworkOriginal article
<![CDATA[First-in-Human: Jyoti Malhotra, MD, MPH on Phase I Trials, Lung Cancer in 2026, and Yale]]>
Phase 1Neutral
AI Analysis
Summary
Dr. Jyoti Malhotra discusses first-in-human Phase 1 clinical trials and lung cancer precision medicine initiatives in 2026, along with her move to Yale Cancer Center. The article focuses on clinical trial methodology and research direction rather than specific drug or trial outcomes.
Clinical Trial Data
Phase
1
Importance:3/10
Sentiment:
0.00
Phase 1 trialslung cancerprecision medicinefirst-in-humanclinical research
Read the original article
Published by Cancer Network on September 28, 2026 7:00 PM